Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.4.2; removed the prior notices about funding lapses and operating status (Revision: v3.4.1).SummaryDifference0.4%

- Check12 days agoChange DetectedNotice about government funding lapse added, stating the NIH Clinical Center is open and directing users to opm.gov for updates. The site revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check19 days agoChange DetectedAdded a glossary display option and updated footer/version information to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check33 days agoChange DetectedRevision: v3.3.4 has been added, and Revision: v3.3.3 has been removed.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded a Locations section showing the California site and updated the page revision from v3.3.2 to v3.3.3. Removed the HHS Vulnerability Disclosure and the California Locations entry.SummaryDifference0.2%

- Check76 days agoChange DetectedRevision: v3.3.2 is shown on the page, and Revision: v3.3.1 has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.